Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Panel A: Molnupiravir Prophylaxis	40
Overall Study	STARTED	Panel B: Molnupiravir Triggered Treatment	36
Overall Study	STARTED	Panel C: Matched Placebo	40
Overall Study	Started Study Medication	Panel A: Molnupiravir Prophylaxis	39
Overall Study	Started Study Medication	Panel B: Molnupiravir Triggered Treatment	36
Overall Study	Started Study Medication	Panel C: Matched Placebo	40
Overall Study	COMPLETED	Panel A: Molnupiravir Prophylaxis	38
Overall Study	COMPLETED	Panel B: Molnupiravir Triggered Treatment	36
Overall Study	COMPLETED	Panel C: Matched Placebo	40
Overall Study	NOT COMPLETED	Panel A: Molnupiravir Prophylaxis	2
Overall Study	NOT COMPLETED	Panel B: Molnupiravir Triggered Treatment	0
Overall Study	NOT COMPLETED	Panel C: Matched Placebo	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT05559905/flow